Healthcare Services

Global Syphilis Immunoassay Diagnostics Industry Trends: Where the Market Is Headed by 2029

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Syphilis Immunoassay Diagnostics Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The syphilis immunoassay diagnostics market size has experienced robust expansion in recent years. It is projected to grow from $31.25 billion in 2024 to $33.5 billion in 2025, at a compound annual growth rate (CAGR) of 7.2%. This historic growth can be attributed to several factors, including the increase in socioeconomic elements such as STDs, a growing percentage of unreported sexual activity, the rising occurrence of severe syphilis diseases, expanding governmental initiatives, and a heightened focus on the early diagnosis of these conditions.

The syphilis immunoassay diagnostics market size is projected to experience substantial expansion over the upcoming years. It is forecast to reach a valuation of $44.26 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.2%. The growth during the forecast period can be attributed to factors such as the swift expansion of the high-risk population, heightened awareness regarding partner notification programs, an increase in prevalence, greater recognition of syphilis immunoassay diagnostics, and a notable rise in government expenditure on healthcare. Major trends anticipated during this period encompass the adoption of innovative technologies, the development of rapid point-of-care tests, a growing demand for home test kits, advancements in laboratory testing methods, and the expansion of diagnostic laboratory techniques.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16806&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Syphilis Immunoassay Diagnostics Industry?

The syphilis immunoassay diagnostics market is projected to grow as sexually transmitted diseases continue to rise. Sexually transmitted diseases (STDs), also referred to as sexually transmitted infections (STIs), are infections primarily transmitted through sexual contact, encompassing vaginal, anal, and oral sex. This increase in STDs is linked to factors such as declining condom use, antibiotic resistance, inadequate sexual education, shifts in social and behavioral patterns, stigma, reduced funding for STD programs, and increased travel. Syphilis immunoassay diagnostics are instrumental in identifying and managing sexually transmitted diseases by providing accurate and timely detection of syphilis infection, which enables appropriate treatment and prevention strategies. For example, in June 2024, a report from the UK-based Terrence Higgins Trust cited the UK Health Security Agency (UKHSA) reporting 401,800 sexually transmitted infections (STIs) in England in 2023, marking a 5% rise from the preceding year. Thus, the escalating incidence of sexually transmitted diseases is a key driver for the syphilis immunoassay diagnostics market.

What Are The Key Segments In The Syphilis Immunoassay Diagnostics Market?

The syphilis immunoassay diagnosticsmarket covered in this report is segmented –

1) By Product: Analyzers; Reagents; Kits; Other Products

2) By Technology: Chemiluminescence Immunoassay (CLIA); Enzyme-Linked Immunosorbent Assay (ELISA); Other Technologies

3) By Application: Men; Women

4) By End-User: Hospitals; Blood Banks; Diagnostics Labs; Other End-Users

Subsegments:

1) By Analyzers: Automated Analyzers; Semi-Automated Analyzers; Manual Analyzers

2) By Reagents: Enzyme-Linked Immunosorbent Assay Reagents; Chemiluminescent Immunoassay Reagents; Rapid Plasma Reagin Reagents; Treponemal and Non-Treponemal Reagents

3) By Kits: ELISA Kits; Rapid Diagnostic Test Kits; CLIA Kits; Point-Of-Care Test Kits

4) By Other Products: Control and Calibration Materials; Sample Collection Devices; Ancillary Testing Accessories

Which Market Trends Are Creating New Opportunities In The Syphilis Immunoassay Diagnostics Industry?

Leading companies within the syphilis immunoassay diagnostics sector are focusing their efforts on creating advanced diagnostic methods, such as rapid syphilis tests, to bolster the effectiveness and precision of identifying syphilis. These rapid tests offer straightforward, point-of-care solutions capable of detecting syphilis antibodies in blood or other bodily fluids within a few minutes, thus facilitating prompt diagnosis and immediate treatment initiation. As an illustration, in February 2023, Chembio Diagnostics Inc., a US-based firm specializing in point-of-care diagnostics for infectious diseases, secured a CLIA waiver from the FDA for its DPP HIV-Syphilis System. This particular system functions as a dual rapid test, engineered to simultaneously identify antibodies for both HIV 1/2 and Treponema pallidum, the bacterium responsible for syphilis. The 15-minute duration of this swift test is intended to advance diagnostic capabilities and improve treatment outcomes, specifically in preventing syphilis transmission from mothers to children and mitigating the risk of HIV acquisition among individuals already affected by syphilis.

Who Are The Core Companies Influencing The Syphilis Immunoassay Diagnostics Market Landscape?

Major companies operating in the syphilis immunoassay diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Meril Life Sciences Pvt. Ltd., Randox Laboratories Ltd., SEKISUI Diagnostics, Bloodworks Northwest, LetsGetChecked, Everlywell Inc., ACON Laboratories Inc., Trinity Biotech, Fujirebio, CTK Biotech Inc., bioLytical Laboratories Inc., AdvaCare Pharma, MyBioSource.com, Gold Standard Diagnostics Frankfurt GmbH, Newmarket Biomedical Ltd, InTec PRODUCTS INC., NuGenerex Diagnostics LLC

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/syphilis-immunoassay-diagnostics-global-market-report

How Is Syphilis Immunoassay Diagnostics Market Demand Varying Across Different Regions?

North America was the largest region in the syphilis immunoassay diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the syphilis immunoassay diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Syphilis Immunoassay Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16806&type=smp

Browse Through More Reports Similar to the Global Syphilis Immunoassay Diagnostics Market 2025, By The Business Research Company

Transplant Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795